Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.
Saved in:
| Title: | Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial. |
|---|---|
| Authors: | Langley, Blake O.1,2 (AUTHOR), Ryan, Jennifer Joan1 (AUTHOR), Phipps, John1 (AUTHOR), Buttolph, Lita1 (AUTHOR), Bray, Brenna1 (AUTHOR), Aslan, Joseph E.3 (AUTHOR), Metz, Thomas O.4 (AUTHOR), Stevens, Jan F.5 (AUTHOR), Bradley, Ryan1,6 (AUTHOR) rbradley@nunm.edu |
| Source: | Trials. 10/22/2022, Vol. 23 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
